Regulatory Readiness
The Market Is Open. The Question Is Whether You Are Ready to Enter It.
Doers, not sayers
Regions like Europe are one of the most valuable and complex markets in the world to enter. The commercial opportunity is real. So is the regulatory infrastructure that governs access to it – and most companies discover its full weight only after they have already committed to a launch timeline.
Regulatory readiness is not a technical formality. It is a commercial decision. And the companies that get it right from the beginning move faster, spend less, and build market positions that last.
What Usually Goes Wrong
Companies that have built a successful product in their home market arrive at European expansion with confidence. The product is proven. The commercial strategy is solid. The team is ready.
What they discover — sometimes months into the process, sometimes at the moment of first audit — is that their documentation was never designed for the destination market. Instructions for use that don’t meet the language and technical requirements of MDR or IVDR. Post-market surveillance structures that satisfy local standards but fail under European Notified Body review. Technical files that clear initial registration but don’t hold up at renewal.
These are not edge cases. They are the standard experience of companies that treated regulatory documentation as an administrative step rather than a commercial one.
The cost is not just financial. It is time — and in market entry, time is the resource you cannot recover.
What We Do About It
KOMPASSIUM integrates regulatory readiness directly into the market entry sequence — not as a separate compliance workstream, but as a foundation that makes the commercial strategy executable.
Working with specialist regulatory documentation partners, we ensure that before your first distributor conversation, your first audit, or your first product on a European shelf, your documentation is aligned, traceable, and built to last.
This covers the core EU entry path — MDR, IVDR, ISO 13485, ISO 14971, multilingual IFU consistency, PMS documentation — as well as what happens after launch: distributor qualification, after-sales documentation, post-market surveillance across distribution networks, and audit readiness as a planned milestone in your growth roadmap rather than a reaction to a problem.
For companies also navigating entry into Brazil or operating along the Europe–LATAM corridor, we extend this work to include ANVISA alignment and the bilateral documentary bridge that cross-market operations demand.
Who This Is For
You are planning to enter the European market and want to understand what regulatory documentation requirements actually mean for your timeline and budget – before you commit to one.
You are already in market entry and have hit a documentation gap that is slowing your commercial progress.
You are preparing for an upcoming regulatory audit—a European Notified Body audit, a distributor qualification, or an ANVISA visit—and want to treat it as a planned event rather than an emergency.
You distribute or plan to distribute through partners in Europe or in other regulated markets, and need the documentary infrastructure to support those relationships long-term.
The Right Moment to Think About This
Before your market entry plan is finalized – not after. Regulatory readiness built into the sequence from the start costs a fraction of what it costs to retrofit it under time pressure.
The first conversation is a 30-minute no-commitment briefing. We define the challenge, the markets involved, and what readiness actually looks like for your specific situation.
